MTOR and cancer: Although autophagy is commonly activated in various types of cancer, previous studies have identified that Ras-driven and mTOR inhibitor-treated tumors exhibit prominently high levels of autophagy contributing to drug resistance, which may be overcome by the administration of autophagy inhibitors, indicating that autophagy inhibition is a potential strategy for overcoming drug resistance in these types of cancer (25–31).